pharma · Complement-mediated Hemolytic Diseases
Nanjing Chia-tai Tianqing
Nanjing Chia-tai Tianqing Pharmaceutical
News and analysis for Nanjing Chia-tai Tianqing on NovaPharmaNews — regulatory, clinical, and market coverage.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Nanjing Chia-tai Tianqing — regulatory, clinical, and market coverage.
News and analysis for Nanjing Chia-tai Tianqing on NovaPharmaNews — regulatory, clinical, and market coverage.